Homology modelling and bivalent single-chain Fv construction of anti-HepG2 single-chain immunoglobulin Fv fragments from a phage display library

Journal of Biosciences

Volumn 33, Issue 5, 2008, Pages 691-697

  Ni, Ming ^b   Yu, Bing ^a   Huang, Yu ^a   Tang, Zhenjie ^a   Lei, Ping ^a   Shen, Xin ^a   Xin, Wei ^a   Zhu, Huifen ^a   Shen, Guanxin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

BsFv; Homology modelling; ScFv; Three dimensional (3D) structure

Indexed keywords

HIRULOG; IMMUNOGLOBULIN FRAGMENT; IMMUNOGLOBULIN FV FRAGMENT; UNCLASSIFIED DRUG;

HOMOLOGY; MODELING; THREE-DIMENSIONAL MODELING;

ANTIBODY COMBINING SITE; ANTIGEN BINDING; ARTICLE; CELL LINE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE THERAPY; HEAVY CHAIN; HUMAN; HUMAN CELL; HYDROPHOBICITY; LIGHT CHAIN; LIVER CANCER; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; SERODIAGNOSIS; WESTERN BLOTTING;

ANTIBODIES; CELL LINE; HEPATOCYTES; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; PEPTIDE LIBRARY; PROTEIN BINDING; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 59449083592     PISSN: 02505991     EISSN: 02505991     Source Type: Journal    
DOI: 10.1007/s12038-008-0089-5     Document Type: Article

References (29)

1. J. R. Adair 1992 Engineering antibodies for therapy Immunol. Rev. 130 5 40
2. R. A. Beckman L. M. Weiner H. M. Davis 2007 Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors Cancer 109 170 179
3. T. K. Bera M. Onda I. Pastan 1998 A bivalent disulfide-stabilized Fv with improved antigen binding to erbB2 J. Mol. Biol. 281 475 483
4. B. Bose D. A. Chugh M. Kala S. K. Acharya N. Khanna S. Sinha 2003 Characterization and molecular modeling of a highly stable anti-hepatitis B surface antigen scFv Mol. Immunol. 40 617 631
5. P. Carter 2001 Improving the efficacy of antibody-based cancer therapies Nat. Rev. Cancer 1 118 129
6. L. S. Cheng A. P. Liu J. H. Yang Y. Q. Dong L. W. Li J. Wang C. C. Wang J. Liu 2003 Construction, expression and characterization of the engineered antibody against tumor surface antigen, p185(c-erbB-2) Cell Res. 13 35 48
7. J. Feng Z. Xie N. Guo B. Shen 2003 Design and assembly of anti-CD16 ScFv antibody with two different linker peptides J. Immunol. Methods 282 33 43
8. C. K. Heng R. Y. Othman 2006 Bioinformatics in molecular immunology laboratories demonstrated modeling an anti-CMV scFv antibody Bioinformation 1 118 120
9. P. Holliger P. J. Hudson 2005 Engineered antibody fragments and the rise of single domains Nat. Biotechnol. 23 1126 1136
10. P. J. Hudson A. A. Kortt 1999 High avidity scFv multimers; diabodies and triabodies J. Immunol. Methods 231 177 189
11. M. Jain N. Kamal S. K. Batra 2007 Engineering antibodies for clinical applications Trends Biotechnol. 25 307 316
12. T. O. Jorgensen S.T. Solem S. Espelid G. W. Warr B. O. Brandsdal A. Smalas 2002 The antibody site in Atlantic salmon; phage display and modeling of scFv with anti-hapten binding ability Dev. Comp. Immunol. 26 201 206
13. A. A. Kortt O. Dolezal B. E. Power P. J. Hudson 2001 Dimeric and trimeric antibodies: high avidity scFvs for cancer targeting Biomol. Eng. 18 95 108
14. A. A. Kortt M. Lah G. W. Oddie C. L. Gruen R. G. Webster P. J. Hudson 1997 Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimer Protein Eng. 10 423 433
15. L. J. Lawrence A. A. Kortt P. Iliades P. A. Tulloch P.J. Hudson 1998 Orientation of antigen binding sites in dimeric and trimeric single chain Fv antibody fragments FEBS Lett. 425 479 484
16. B. Li H. Wang D. Zhang W. Qian S. Hou S. Shi L. Zhao G. Kou Z. Cao J. Dai Y. Guo 2007 Construction and characterization of a high-affinity humanized SM5-1 monoclonal antibody Biochem. Biophys. Res. Commun. 357 951 956
17. P. Martineau P. Jones G. Winter 1998 Expression of an antibody fragment at high levels in the bacterial cytoplasm J. Mol. Biol. 280 117 127
18. K. Merienne N. Germain S. Zinn-Justin J. C. Boulain F. Ducancel A. Menez 1997 The functional architecture of an acetylcholine receptor-mimicking antibody J. Biol. Chem. 272 23775 23783
19. D. Muller R. E. Kontermann 2007 Recombinant bispecific antibodies for cellular cancer immunotherapy Curr. Opin. Mol. Ther. 9 319 326
20. E. C. Peterson E. M. Laurenzana W. T. Atchley H. P. Hendrickson S. M. Owens 2008 Development and preclinical testing of a high-affinity single-chain antibody against (+)-methamphetamine J. Pharmacol. Exp. Ther. 325 124 133
21. L. Presta 2003 Antibody engineering for therapeutics Curr. Opin. Struct. Biol. 13 519 525
22. H. Saenz L. Lareo R. A. Poutou A. C. Sosa L. A. Barrera 2007 Computational prediction of the tertiary structure of the human iduronate 2-sulfate sulfatase Biomedica 27 7 20
23. T. C. Thomas S. A. Rollins R. P. Rother M. A. Giannoni S. L. Hartman E. A. Elliott S. H. Nye L. A. Matis S. P. Squinto M. J. Evans 1996 Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv Mol. Immunol. 33 1389 1401
24. A. Todorovska R. C. Roovers O. Dolezal A. A. Kortt H. R. Hoogenboom P. J. Hudson 2001 Design and application of diabodies, triabodies and tetrabodies for cancer targeting J. Immunol. Methods 248 47 66
25. D. J. Turner M. A. Ritter A. J. George 1997 Importance of the linker in expression of single-chain Fv antibody fragments: optimisation of peptide sequence using phage display technology J. Immunol. Methods 205 43 54
26. T. Volkel T. Korn M. Bach R. Muller R. E. Kontermann 2001 Optimized linker sequences for the expression of monomeric and dimeric bispecific single-chain diabodies Protein Eng. 14 815 823
27. W. W. Wang D. Das S. A. McQuarrie M. R. Suresh 2007 Design of a bifunctional fusion protein for ovarian cancer drug delivery: single-chain anti-CA125 core-streptavidin fusion protein Eur. J. Pharm. Biopharm. 65 398 405
28. B. Yu M. Ni W. H. Li P. Lei H. F. Zhu G. X. Shen 2005 Human scFv antibody fragments specific for hepatocellular carcinoma selected from a phage display library World J. Gastroenterol. 11 3985 3989
29. Q. C. Zheng Z. S. Li M. Sun Y. Zhang C. C. Sun 2005 Homology modeling and substrate binding study of Nudix hydrolase Ndx1 from Thermos thermophilus HB8 Biochem. Biophys. Res. Commun. 333 881 887